Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Human CXCL9/MIG Protein, N-His

Catalog #:   YHG11901 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q07325
Protein length: Thr23-Thr125
Overview

Catalog No.

YHG11901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Thr23-Thr125

Predicted molecular weight

14.02 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q07325

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

CMK, HuMIG, Monokine induced by interferon-gamma, Small-inducible cytokine B9, C-X-C motif chemokine 9, MIG, CXCL9, SCYB9, Gamma-interferon-induced monokine

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human CXCL9/MIG
References

Physical activity affects DNA methylation-derived inflammation markers in a community-based Parkinson's disease study., PMID:40510182

Detection of Kidney Allograft Rejection Using Urinary Chemokines., PMID:40504617

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer., PMID:40492347

Microenvironment-Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning., PMID:40491292

Distinct proteomic signatures in Ethiopians predict acute and long-term sequelae of COVID-19., PMID:40475767

Proteomic and metabolomic profiling of extracellular vesicles produced by human gut archaea., PMID:40461460

Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome., PMID:40443809

Caveolin-1 Deficiency in Macrophages Alleviates Carbon Tetra-Chloride-Induced Acute Liver Injury in Mice., PMID:40430042

Urinary NGAL Outperforms 99mTc-MAG3 Renography in Predicting DCD Kidney Graft Function., PMID:40421388

Rubia cordifolia L. extract ameliorates vitiligo by inhibiting the CXCL10/CXCL9/STAT1 signaling pathway., PMID:40412781

Impact of Smoking on Macrophage-Related Chemokines During Initial Peri-Implantitis: A Prospective Cohort Study., PMID:40399133

A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease., PMID:40392411

Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+ fibroblasts and ACKR1+ endothelial cells in immune-related myocarditis., PMID:40380233

Autophagy inhibition amplifies anti-tumor immunity effect of dinutuximab beta on neuroblastoma via the VEGFR/AKT/mTOR and ROS/NF-κB pathways., PMID:40378433

Screening and identification Hub genes associated with immune cell infiltration and critical biomarkers in osteosarcoma., PMID:40374042

The Influence of an Acute Endurance Intervention on Breast Cancer Cell Growth-A Pilot Study., PMID:40362215

Influence of Exogenous Neuropeptides on the Astrocyte Response Under Conditions of Continuous and Cyclic Hypoxia and Red Blood Cell Lysate., PMID:40362194

Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice., PMID:40360777

Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies., PMID:40357378

Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity., PMID:40356899

Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer., PMID:40346805

CXCL9 is a dual‑role biomarker in colorectal cancer linked to mitophagy and modulated by ALKBH5., PMID:40341964

Comprehensive bioinformatics analysis uncover molecular pathways shared between osteoarthritis and atherosclerosis., PMID:40335993

The interplay between systemic inflammation and myopia: A bidirectional Mendelian randomization and experimental validation study., PMID:40327989

Defining a non-eosinophilic inflammatory subtype in COPD: the role of CXCL9 and type 1 immune responses., PMID:40313944

Inhibition of MBTPS1 enhances antitumor immunity and potentiates anti-PD-1 immunotherapy., PMID:40307212

Proteomic Profiling of Inflammatory Protein Dysregulation in HLA-B27-Positive Ankylosing Spondylitis: Molecular Signatures and Potential Biomarkers., PMID:40305235

Plasma Levels of CXCL9 and MCP-3 are Increased in Asthma-COPD Overlap (ACO) Patients., PMID:40297845

Low levels of DNA repair enzyme NEIL2 May exacerbate inflammation and genomic damage in subjects with stable COPD and during severe exacerbations., PMID:40296120

Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma., PMID:40294469

Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study., PMID:40276503

Exploration of the association between 91 inflammatory proteins and immune thrombocytopenia: a two-sample Mendelian randomization analysis., PMID:40261473

Psychosocial stress and associations with inflammation in mid-gestation maternal, fetal, and placental tissue., PMID:40254104

Parabacteroides distasonis promotes CXCL9 secretion of tumor-associated macrophages and enhances CD8+T cell activity to trigger anti-tumor immunity against anti-PD-1 treatment in non-small cell lung cancer mice., PMID:40241108

Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy., PMID:40238455

The dual role of CXCL9/SPP1 polarized tumor-associated macrophages in modulating anti-tumor immunity in hepatocellular carcinoma., PMID:40230843

Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary Sjögren's syndrome., PMID:40227387

Salivary chemokines and growth factors in patients with ischemic stroke., PMID:40221607

NCOA3 impairs the efficacy of anti-PD-L1 therapy via HSP90α/EZH2/CXCL9 axis in colon cancer., PMID:40215778

Effect of microglial Pd1 on glial scar formation after spinal cord injury in mice., PMID:40209954

Identifying gene expression predictive of response to neoadjuvant endocrine therapy in early breast cancer., PMID:40205245

Fecal microbiota transplantation enhanced the effect of chemoimmunotherapy by restoring intestinal microbiota in LLC tumor-bearing mice., PMID:40200137

Integrated single-cell and spatial analysis identifies context-dependent myeloid-T cell interactions in head and neck cancer immune checkpoint blockade response., PMID:40196610

CXCL Gene Clusters Regulated by Enhancer-Mediated DNA Looping Alteration in Pancreatic Cancer Cells., PMID:40194986

CXCL9 and IL-18: potential biomarkers for efficacy evaluation in refractory hemophagocytic lymphohistiocytosis treated with RED (ruxolitinib, emapalumab and dexamethasone)., PMID:40186662

Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides., PMID:40181256

Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study., PMID:40179922

PAR2 deficiency impairs antitumor immunity and attenuates anti-PD1 efficacy in colorectal cancer., PMID:40174816

Cxcr3 promotes protection from colorectal cancer liver metastasis by driving NK cell infiltration and plasticity., PMID:40168086

Epithelial Ikkβ deletion modulates immune responses and the IFNγ/CXCL9 axis during early esophageal carcinogenesis., PMID:40166246

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human CXCL9/MIG Protein, N-His [YHG11901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only